SEPN Stock Analysis: Buy, Sell, or Hold?
SEPN - Septerna, Inc. Common Stock
$23.34
-0.46 (-1.93%)
▼
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 26, 2026
Get Alerted When SEPN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SEPN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: SEPN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: SEPN is currently trading at $23.34, which is considered oversold relative to its 30-day fair value range of $24.86 to $27.89.
Technical Outlook: Technically, SEPN is in a strong uptrend. The price is currently testing key support at $23.23. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SEPN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $33.86 (+45.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SEPN is in a strong uptrend. The price is currently testing key support at $23.23. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SEPN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $33.86 (+45.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$24.86 -
$27.89
Company Quality Score
46/100
(HOLD)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
60.4%
Protect Your Profits
Holding SEPN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 45.1% below Wall St target ($33.86)
- CAUTION: Recommendation downgraded due to -9.4% 5-day decline
Fair Price Analysis
30-Day Fair Range
$24.86 -
$27.89
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$2.08
(8.9%)
Support & Resistance Levels
Support Level
$23.23
Resistance Level
$28.15
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-27.83
Wall Street Target
$33.86
(+45.1%)
Revenue Growth (YoY)
12113.1%
Profit Margin
-266.8%
Last updated: February 01, 2026 1:23 AM ET
Data refreshes hourly during market hours. Next update: 2:23 AM
Data refreshes hourly during market hours. Next update: 2:23 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SEPN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$500 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 64 BUY |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$214 | 60 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$830 | 52 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$89 | 61 BUY |
Advanced SEPN Option Strategies
Professional options setups generated by AI based on today's SEPN price and gamma walls.
